Upstream Bio, Inc. (UPB)
7.18
+0.57
(+8.62%)
USD |
NASDAQ |
Aug 25, 16:00
7.18
0.00 (0.00%)
After-Hours: 19:59
Upstream Bio Shareholders Equity (Quarterly) : 270.96M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 270.96M |
| March 31, 2026 | 304.00M |
| December 31, 2025 | 339.77M |
| September 30, 2025 | 378.58M |
| Date | Value |
|---|---|
| June 30, 2025 | 408.74M |
| March 31, 2025 | 445.61M |
| December 31, 2024 | 469.85M |
| September 30, 2024 | 220.56M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sutro Biopharma, Inc. | -103.32M |
| Compass Therapeutics, Inc. | 166.05M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 281.17M |
| Total Liabilities (Quarterly) | 10.21M |
| Debt to Equity Ratio | 0.0035 |
| Current Ratio | 27.99 |
| Net Debt Paydown Yield | 0.04% |